A One Year, Multi-center, Randomised, Double-blind Placebo-controlled Parallel-groups Assessment of the Tolerability, Safety and Efficacy of Epanova Soft Gelatin Capsules 4g/Day for Maintenance of Remission of Crohn's Disease.
Phase of Trial: Phase III
Latest Information Update: 03 Apr 2013
At a glance
- Drugs Omega-3 carboxylic acids (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms EPIC-1
- Sponsors Tillotts Pharma
- 31 Aug 2018 Biomarkers information updated
- 25 Feb 2008 New trial record.